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ABSTRACT 
 The yellow-bellied sea snake, Pelamis platura, is the most broadly distributed snake 
species. Despite being endowed with a highly lethal venom, a proteomic analysis of its 
toxin composition was unavailable. The venoms of specimens collected in Golfo de 
Papagayo and Golfo Dulce (Costa Rica), where two distinctive color morphs occur, were 
chromatographically compared. The latter inhabits a fjord-like gulf where the transit of 
oceanic sea snakes into and from the basin is restricted, thus possibly affecting gene flow. 
RP-HPLC evidenced a conserved venom protein profile in both populations, despite their 
divergent color phenotypes. Following a trend observed in other sea snakes, P. platura 
venom is relatively simple, being composed of proteins of the three-finger toxin (3FTx), 
phospholipase A2 (PLA2), cysteine-rich secretory protein (CRISP), 5'-nucleotidase, and 
metalloproteinase families. The first three groups represent 49.9%, 32.9%, and 9.1% of 
total venom protein, respectively. The most abundant component (~26%) is pelamitoxin 
(P62388), a short-chain 3FTx, followed by a major basic PLA2 (~20%) and a group of three 
isoforms of CRISPs (~9%). Whereas isolated pelamitoxin was highly lethal to mice, neither 
the PLA2 nor the CRISP fraction caused death. However, the PLA2 rapidly increased 
plasma creatine kinase activity after intramuscular injection, indicating its myotoxic action. 
Differing from myotoxic PLA2s of viperids, this PLA2 was not cytolytic to murine 
myogenic cells in vitro, suggesting possible differences in its mechanism of action. The 
median lethal dose (LD50) estimates for P. platura crude venom in mice and in three 
species of fishes did not differ significantly. The sea snake antivenom manufactured by 
CSL Ltd. (Australia), which uses Enhydrina schistosa as immunogen, cross-recognized the 
three major components of P. platura venom and, accordingly, neutralized the lethal 
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activity of crude venom and pelamitoxin, therefore being of potential usefulness in the 
treatment of envenomations by this species. (297 words) 
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1. INTRODUCTION 
 Snake venoms are complex mixtures of bioactive molecules, including enzymes, 
non-enzymatic proteins, and several inorganic components [1]. In the last fifteen years, the 
application of proteomic methods to assess the compositional diversity of venoms has 
revolutionized our knowledge of toxic secretions in advanced snakes, leading to a deeper 
understanding of their biological functions and medical implications [2-6]. Not 
surprisingly, most studies in ‘venomics’ have been conducted in species of great medical 
importance, although the description of venoms from other species continues. These studies 
convey that an integral catalog of the secreted toxins is needed in order to fully understand 
the pathophysiology of envenomations and to improve their treatments [7]. In addition, 
assessing venom proteomes provides insights into the evolution of toxins and the contexts 
in which they evolved [8]. In some cases, phylogenetically related snake species resemble 
each other in venom activity and composition [9,10], and thus venom makeup could result 
from the evolutionary history of those species [11]. However, both substantial divergences 
and convergences in toxin constituents and/or their proportions have also been noticed 
between closely related species as well as between phylogenetically distant taxa [12-14]. 
Since venom denotes a key adaptation to subdue and digest prey, this situation implies that 
venom variation also results from natural selection acting upon differences in the identity or 
type of prey [13-15]. 
 Regardless of the causes that shape it, venom variation endows snakes with the 
ability to adapt to different ecological niches and to diversify within them. One group that 
has recently done so is comprised by the true sea snakes (Hydrophiinae: Hydrophiini), a 
clade of nearly sixty species of elapids that diverged from a common ancestor and 
experienced rapid radiation in the last 1.5-3 million years [16]. The Hydrophiini evolved 
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the ability to persist in the severe conditions imposed by marine environments: high levels 
of solar radiation and salinity, extreme temperatures, and underwater shelters. They present 
a characteristic paddle-like tail that enhances their swimming ability, and are 
ovoviviparous, spending most of their lives in their aquatic habitats [17,18]. Most sea 
snakes are benthic predators that exhibit great diet specialization and are constantly looking 
for prey in crevices of rocks and corals, or on the muddy bottom of their habitats [19]. A 
notable exception to these modes is the yellow-bellied sea snake Pelamis platura (recently 
proposed to change to Hydrophis platura; [16]), the only truly pelagic species that 
completes its lifecycle in the water column [20]. 
 The yellow-bellied sea snake is an abundant species throughout most of its range, 
and can be often observed floating on the surface of slicks, i.e. long smooth lines in the 
surface where sea currents converge [21,22]. Unlike other sea snakes [23], P. platura feeds 
on a variety of small fishes on the water surface [21,24-26]. Its venom contains 
pelamitoxin, a three-finger toxin (3FTx) acting as potent postsynaptic blocker with high 
lethality to experimental animals [27,28]. Despite P. platura being a widespread sea snake 
species with a highly lethal venom, a comprehensive account of its venom constituents was 
still lacking, perhaps as a consequence of its low medical impact. 
 Along its broad distribution in tropical and subtropical waters of the Indo-Australian 
region and the Pacific coast of the American continent [29], the largest for any snake 
species, two types of populations have been described for P. platura [30]: those restricted 
to particular areas in warm temperature waters (i.e. resident populations); and those 
composed of individuals that drift in currents throughout a wider region (i.e. waif 
populations, often in cooler waters). A resident population of P. platura restricted to the 
Golfo Dulce, in southwestern of Costa Rica, was reported recently [31]. In this locality, 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 6 
most individuals are bright yellow (Fig.1D), but this morph is extremely rare in other 
localities of the species distribution [21,22,24]. Dominance of the yellow-morph in this 
locality might reflect gene flow restrictions. Biogeographically, Golfo Dulce is a fjord-type 
gulf, where the sea water enters slowly [32,33] and restricts the movement of oceanic sea 
snakes into and from the basin [31,34]. In contrast, the population off the Pacific coast of 
Costa Rica exhibits a typical bicolored or tricolored pattern (Fig.1A) that prevails 
elsewhere along the species distribution [24,25]. 
 The apparent restriction of gene flow in these distinct color-morph populations is of 
great interest [35] because it could lead to differences in the expression of venom 
constituents, and in turn could reveal differences in the evolutionary forces that underlie 
venom variation in this sea snake, as observed in other wide-ranging venomous snakes 
[36,37]. Therefore, the present study first compared the chromatographic profiles of 
the venoms of these two morphologically distinctive populations of P. platura from 
Costa Rica, and then, since they showed identical chromatograms, the venom 
composition of P. platura from Golfo Dulce was analyzed using venomics and the 
assessment of several in vitro and in vivo activities. In addition, the neutralization of 
this venom by a sea snake antivenom from Australia was evaluated. 
 
 
2. MATERIALS AND METHODS 
2.1 Venom samples 
 Adult individuals of P. platura were collected at approximately 2 Km from the 
shore, at two locations along the Pacific coast of Costa Rica (Fig.1B): Golfo de Papagayo 
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(~10°34'30''N, 85°43'19'' W; Guanacaste province; 47 individuals), and Golfo Dulce 
(~8°35'36'' N, 83°16'09'' W; Puntarenas province, 84 individuals). At the first location, all 
individuals exhibited the bicolored or tricolored pattern of the yellow-bellied sea snake, 
whereas all individuals from the second locality were yellow morphs. Venom was extracted 
directly into non-heparinized microhematocrit tubes, and specimens were thereafter 
released near their collecting sites. Venoms from each of the two populations were pooled, 
and finally conserved by freeze-drying and storage at -20°C. 
 
2.2 Reverse-phase HPLC comparative profiling 
 The venoms (~2 mg) of P. platura from Golfo de Papagayo or Golfo Dulce, 
respectively, were dissolved in 200 L of water containing 0.1% trifluoroacetic acid (TFA), 
centrifuged at 15,000 xg for 5 min to remove debris, and fractionated by RP-HPLC on a 
C18 column (Teknokroma; 4.6 x 250 mm, 5 m particle) using an Agilent 1200 
chromatograph. Elution was performed at 1 mL/min by applying a gradient towards 
solution B (acetonitrile, containing 0.1% TFA), as follows: 0% B for 5 min, 0-15% B over 
10 min, 15-45% B over 60 min, 45–70% B over 10 min, and 70% B over 9 min. 
Absorbance of the eluent was recorded at 215 nm and chromatograms were compared using 
the ChemStation B.04.01 software (Agilent). 
 
2.2 Venomic characterization 
 Since the comparison by RP-HPLC of the venoms of P. platura from Golfo de 
Papagayo and Golfo Dulce did not reveal differences (Fig.2), only the venom from Golfo 
Dulce was subsequently analyzed following the 'snake venomics' strategy [4,38], with 
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slight modifications [10]. Briefly, HPLC fractions were collected manually, dried in a 
vacuum centrifuge, re-dissolved in water, and further separated by SDS-PAGE under 
reducing conditions (5% 2-mercaptoethanol at 100°C for 5 min) in 12% gels. After 
Coomassie blue R-250 staining, gel images were recorded using ChemiDoc/ImageLab 
(Bio-Rad) for densitometry analysis, which was combined with the integration of 
chromatographic peak areas to obtain estimates of protein relative abundances. Protein 
bands were then excised and subjected to in-gel reduction (10 mM dithiothreitol), 
alkylation (50 mM iodacetamide), and overnight digestion with trypsin in a ProGest 
processor (Digilab), following manufacturer's recommendations. The resulting peptides 
were extracted and characterized by tandem mass spectrometry, as described below. 
 
2.3 Mass spectrometry 
 Tryptic digests were dried in vacuo, redissolved in 10-40 l of 0.1% formic acid, 
depending on band size, and submitted to nano-UPLC-ESI-MS/MS mass spectrometry. 
Toward this end, tryptic peptides were separated by nano-Acquity UltraPerformance LC
®
 
(UPLC
®
) using a BEH130 C18 column (100 µm x 100 mm, 1.7µm particle) on-line with a 
Waters SYNAPT G2 High Definition Mass Spectrometry System. The flow rate was set to 
0.6 µl/min and the column was developed with a linear gradient of 0.1% formic acid in 
water (solution A) and 0.1% formic acid in acetonitrile (solution B), isocratically 1% B for 
1 min, followed by 1-12% B for 1min, 12-40% B for 15min, 40-85% B for 2min. Doubly- 
and triply-charged ions were selected for collision-induced dissociation (CID) MS/MS. 
Fragmentation spectra were interpreted manually, processed in ProteinLynx Global 
SERVER 2013 version 2.5.2., or by using the online form of the Mascot program at 
http://www.matrixscience.com against the NCBI non-redundant database. MS/MS mass 
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tolerance was set to ± 0.6 Da. Carbamidomethyl cysteine, and propionamide cysteine and 
oxidation of methionine were fixed and variable modifications, respectively. Some tryptic 
peptides were analyzed by MALDI-TOF-TOF on a 4800 Plus Proteomics Analyzer 
(Applied Biosystems) using -cyano-hydroxycinnamic acid as matrix, under previously 
described conditions [10]. 
 
2.4 Venom lethality 
 Animal experiments were conducted in CD-1 mice of either sex, following 
protocols approved by the Institutional Committee for the Use and Care of Animals 
(CICUA), University of Costa Rica. Mice were housed in cages for groups of 4-6, and 
provided food and water ad libitum. The lethal potency of the venom was tested by 
intraperitoneal (i.p.) and intravenous (i.v.) routes, respectively, in groups of five mice of 
16-18 g body weight. Deaths induced by the injection of varying doses of venom (1.25-10 
g), dissolved in 0.12 M NaCl, 0.04 M sodium phosphate buffer (PBS; pH 7.2), were 
recorded after 48 hr. The median lethal dose (LD50) was estimated by probits. In addition, 
the lethal potency of the crude venom was tested in three species of fish: spotted snapper 
Lutjanus guttatus (Lutjanidae), scissortail damselfish Chromis atrilobata (Pomacentridae), 
and sleeper goby Dormitator maculatus (Eleotridae), after permits issued by the Ministry of 
Environment of Costa Rica SINAC-ACAT 069-2012. The first two are common species off 
the Pacific coast of Costa Rica and thus are sympatric with both populations of P. platura, 
and at least C. atrilobata has been observed by one of the authors (M. Sasa) to be a prey for 
this snake.  The sleeper goby is a freshwater species, abundant in permanent creeks along 
the Pacific coast of Central America. Venom was injected by i.p. route in groups of five 
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fishes of similar weight (variation coefficient <10%), kept in 20 L aquaria. Water (marine 
or freshwater) temperature was maintained at 22 °C, and varying doses of venom (0.02-
1.50 g), dissolved in distilled water, were adjusted for the mean weight of the group. 
Deaths were recorded after 48 hours, and the LD50 was estimated by probits. 
 
2.5 Myotoxic activity 
 Groups of four mice (18-20 g body weight) received an intramuscular (i.m.) venom 
injection of 1 or 2 µg, respectively, in 50 µL of PBS, into their right gastrocnemius. A 
control group was treated with PBS alone. After three hours, blood samples were obtained 
from the tip of the tail and collected into heparinized capillary tubes; then, after 
centrifugation, the plasma creatine kinase (CK) activity was determined using a UV kinetic 
assay (CK-Nac, Biocon Diagnostik) [39]. CK activity was expressed in units/L. Mice were 
euthanized by CO2 inhalation 6 h after venom injection, and samples of the injected muscle 
tissue were obtained, fixed in 10% formalin, embedded in paraffin, and processed for 
histologic evaluation of hematoxylin/eosin-stained sections. 
 
2.6 Cytotoxic activity 
 The cytotoxic effect of the venom was assayed on the murine myogenic cell line 
C2C12 (ATCC CRL-1772), as described [40]. Varying amounts of venom, diluted in 150 
L of Dulbecco’s Modiﬁed Eagle’s Medium supplemented with 1% fetal calf serum (assay 
medium; DMEM, 1% FCS), were added to near-confluent cell monolayers in 96-well 
plates, after removal of growth medium (DMEM, 10% FCS), in triplicate wells. Cells were 
tested both in their myoblast stage and after differentiation to multinucleated myotubes, 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 11 
obtained 4-6 days after confluence, grown in the presence of 1% FCS. Controls for 0 and 
100% toxicity consisted of assay medium, and 0.1% Triton X-100 diluted in assay medium, 
respectively. After 3 h at 37 °C, cell supernatants were collected to determine the lactic 
dehydrogenase (LDH) activity released from damaged cells, using a UV kinetic assay 
(LDH-P, Wiener Laboratories). Venom of the Central American coral snake, Micrurus 
nigrocinctus (Elapidae), was included as a comparative control. 
 
2.7 Phospholipase A2 activity 
 Venom phospholipase A2 (PLA2) activity was determined on the monodisperse 
synthetic substrate 4-nitro-3-octanoyl-benzoic acid (NOBA) [41]. Varying amounts of 
venom, dissolved in 25 µL of water, were added to 200 µL of 10 mM Tris, 10 mM CaCl2, 
0.1 M NaCl, pH 8.0, in triplicate wells of a microplate. After mixing, 25 µL of NOBA (1 
mg/mL in acetonitrile) were added, to achieve a final substrate concentration of 0.32 mM. 
The mixtures were incubated for 60 min at 37 ºC, and absorbances at 405 nm were 
recorded. PLA2 activity was expressed as the change in absorbance x 1000. Venom of the 
Central American coral snake, Micrurus nigrocinctus (Elapidae), was included as a 
comparative control. 
 
2.8 Neutralization of lethality by antivenom 
 The ability of the equine CSL Ltd. sea snake antivenom (Victoria, Australia; batch 
054908201, expiry date 04-2015; 167 g protein/L) to neutralize the lethal effect of P. 
platura venom was tested in mice. Mixtures were prepared containing a fixed 
venom/antivenom ratio (0.2 mg/mL), and incubated at 37 ºC for 30 min. This single ratio 
was chosend on the basis of the authors' experience on the potency of antivenoms against 
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other elapidic venoms such as Micrurus nigrocinctus. Then, aliquots of the mixture, 
containing four LD50 of venom, were injected either i.p. or i.v. into CD-1 mice (16-18 g). 
Control mice received four LD50 of venom incubated with PBS instead of antivenom. 
Deaths occurring during 48 h were recorded. The neutralizing ability of this antivenom was 
additionally tested against the lethal effect of the isolated major neurotoxin of the venom 
(pelamitoxin). Control mice received an i.v. injection containing four LD50 of toxin alone, 
whereas a mixture of toxin and antivenom (0.2 mg toxin/ml antivenom), preincubated for 
30 min at room temperature, was injected to another group of mice under otherwise 
identical conditions. In addition, the equine Central American coral snake antivenom 
(Elapidae) manufactured at Instituto Clodomiro Picado (University of Costa Rica; batch 
5200313, expiry date March 2016; 30 g protein/L) was tested against the crude venom of P. 
platura, under identical conditions as for the CSL sea snake antivenom. 
 
2.9 Immunochemical analyses 
 The cross-recognition of P. platura venom and its three major components (peaks 1-
-2, 9, and 16; see Results) by the CSL antivenom was analyzed by enzyme-immunoassay 
(EIA) [42] and gel immunodiffusion (GID) [43]. In EIA, whole venom (1 g/well) or 
fractions (0.2 g/well) were adsorbed onto 96-well microplates in 100 L of 0.1 M Tris, 
0.15 M NaCl, pH 9.0 buffer by overnight incubation at room temperature, in duplicate. 
After five washings with PBS, non-specific binding sites were blocked with 100 L of PBS 
containing 2% bovine serum albumin (BSA) for 30 min. Varying dilutions of CSL 
antivenom, prepared in 0.2% BSA-PBS, were then incubated for 2 h, followed by five 
washings with PBS. Bound antibodies were detected by addition of an anti-horse 
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immunoglobulin-alkaline phosphatase conjugate (Sigma), diluted 1:3000 in 0.2% BSA-
PBS, and further incubation for 2 h. After four washings with PBS, and a final wash with 
0.05 M Tris, 0.15 M NaCl, 20 M ZnCl2, 1 mM MgCl2, pH 7.4 buffer, color was developed 
with p-nitrophenylphosphate (1 mg/ml in diethanolamine buffer, pH 9.8) for 30 min and 
measured in a microplate reader (Thermo) at 405 nm. Normal equine serum from a non-
immunized animal was included as a control for background signal. 
 GID was performed in 1% agarose dissolved in PBS, pH 7.2. Wells were punched 
and filled with 40 L of either CSL antivenom, whole venom, or each of the three major 
venom components described above. After 24 h of diffusion at room temperature, 
precipitation lines were recorded using the ChemiDoc/ImageLab software. 
  
2.10 Statistical tests 
 Results of in vitro assays are presented as mean ± SD. Comparisons between means 
of two groups were performed with the Student’s t-test, and values of p<0.05 were 
considered significant. Venom LD50 estimations for each in vivo model (mice or fishes) 
were conducted under a probit model. The goodness of fit of each data set to the model was 
evaluated using Chi
2
 tests.  The LD50 values for each species were compared using the 
doses ratio test [44] implemented in POLO-Plus (LeOra Software, version 2.0). This test 
computes the ratio of one lethal dose to another and estimates 95% confidence intervals for 
each ratio using the parameters of the probit function. The ratio test is a more powerful 
method of comparison than the classical analysis of confidence interval overlap [45].  
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 14 
3. RESULTS AND DISCUSSION 
 As reported in the literature [31,34,46], obvious color pattern differences were 
found in the two populations of P. platura sampled (Golfo de Papagayo and Golfo Dulce). 
Individuals from the latter location exhibited a mostly patternless, yellow body coloration 
phenotype (Fig.1D), differing from the black dorsum/yellow-bellied morphology (Fig.1A) 
most commonly reported for this species in the Golfo de Papagayo. Due to the conspicuous 
phenotypic differences, and considering that the population inhabiting Golfo Dulce, a fjord-
like gulf protected from strong surface currents, might have been genetically isolated from 
the oceanic coastal populations [31,43,35], venom variation between the two color morphs 
was assessed. As shown in Fig.2, a comparison of their venom RP-HPLC profiles revealed 
a conserved phenotype, and thus the distinctive color pattern variation between these two 
populations is not associated with any significant differences in their expression of venom 
proteins. 
 The chromatographic profile of P. platura venom appears relatively simple 
(Fig.3), and shows similarities to those of venoms from some terrestrial elapids analyzed in 
our laboratories using the same methodology, such as the African spitting cobras [47] and 
some coral snakes [48,49], or the marine elapid Hydrophis cyanocinctus [50]. The venom 
of P. platura was separated into twenty fractions (Fig.3), and 32 out of the 36 protein bands 
obtained after electrophoretic separation of the chromatographic peaks could be assigned to 
known protein families following in-gel digestion and tandem mass spectrometry (Table 1). 
The scarcity of venom precluded pursuing further the identification of few minor 
components that remained unknown (altogether <1.5% of the protein content). As 
represented in Fig.1C, half of the protein constituents of P. platura venom belong to the 
three-finger toxin (3FTx) family (49.9%), whereas one-third correspond to PLA2s (32.9%). 
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Cysteine-rich secretory proteins (CRISP) also represent a considerable proportion of this 
venom (9.1%), but only a few other types of commonly found snake venom components 
were detected, including 5'-nucleotidases (5'-NU) and metalloproteinases (SVMP), both 
below 1% in relative protein abundance (Fig.1C). In agreement with the colorless visual 
aspect of this venom, L-amino acid oxidase (which provides yellow color to snake venoms 
owing to its typical adsorption maxima at 465 and 380 nm due to the flavide adenine 
dinucleotide cofactor [51]) was not detected. Altogether, these findings follow the general 
trend observed for sea snake venoms, which biochemically tend to be simpler than those of 
terrestrial venomous snakes [17]. Unexpectedly, low amounts of hemoglobins  and  
(2.1%), albumin (1.1%), and transferrin (1.8%) were identified in the venom (Fig.1C), but 
their presence could be explained by mild contamination with blood, possibly due to slight 
trauma during the difficult venom extraction procedure for this snake species. In addition, 
transferrin has previously been reported in the proteomic analysis of at least one snake 
venom, that of Pseudechis australis [52], therefore the possibility of its presence 
representing a true product of venom gland secretion in P. platura cannot be ruled out. 
 Among the various 3FTx components of P. platura venom, internal peptide 
sequences characteristic of both "short-chain" (type I) and "long-chain" (type II) subgroups 
of this protein family were identified (Table 1), in agreement with the early origin of these 
two types of 3FTx in elapid snakes, before the division between terrestrial Australian 
elapids and sea snakes, and terrestrial African and Asian elapids [53]. 3FTxs often display 
-neurotoxic activity by means of their high-affinity binding to nicotinic acetylcholine 
receptor in the motor end-plate at the neuromuscular junction of diverse groups of animals 
[54], therefore showing potent paralyzing and lethal effects. The most abundant component 
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of P. platura venom (~26%; peaks 1-2 of Table 1) was identified as "pelamitoxin a" 
(P62388), a short-chain 3FTx previously isolated and sequenced [27,28,55]. The existence 
of an isoform named "pelamitoxin b" was reported later [56], differing from the former by a 
single amino acid at the tenth residue (Q/E), and this might explain the close elution and 
undistingushable isotope-averaged molecular mass observed for the overlapping peaks 1-2 
(Fig.3), which were pooled for further functional and immunochemical analyses. 
Expectedly, the various 3FTx peptide sequences obtained showed high similarity to 
proteins from phylogenetically-related marine elapid genera such as Enhydrina, Hydrophis, 
Lapemis, and from diverse terrestrial elapids (Table 1). Likewise, the PLA2 peptide 
sequences obtained are closely related to those of basic enzymes previously reported in 
these snake genera [57-60]. 
 The three most abundant components of P. platura venom (peaks 1-2: 3FTx 
pelamitoxin; peak 9: PLA2; and peak 16: CRISP) were collected for further study, and their 
possible roles in the toxic activities of this venom were evaluated. The crude venom was 
highly lethal to mice. By the i.p. route, its estimated LD50 was 2.3 g/mouse (95% 
confidence limits: 1.5-3.6 g; 0.13 g/g body weight), whereas by the i.v. route the LD50 
was 3.9 g/mouse (95% confidence limits: 0.8-6.4 g; 0.23 g/g body weight). These 
estimates agree with an earlier report on the venom of P. platura from the Guanacaste 
province in Costa Rica by Bolaños et al. [61], who reported it being the "most fluid, the 
most rapidly absorbed, the most potent for mice, and the most homogeneous of the venoms 
of Costa Rican snakes", as well as with other studies compiled by Mackessy and Tu [17]. In 
lethality experiments, mice showed signs of neurotoxicity few minutes after injection, with 
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evident difficulty for breathing, and died within the first 20 min. Mice that did not die 
within this short time span survived the rest of assay. 
 Crude P. platura venom was also highly toxic to sympatric marine (m) and 
allopatric freshwater (fw) fishes: estimated LD50 values by the i.p. route were 0.11 g/g 
(95% confidence limits: 0.06-0.24 g) for Lutjanus guttatus (m); 0.26 g/g (0.04-0.31 g) 
for Chromis atrilobata (m); and 0.089 g/g (0.04-0.17 g) for Dormitator maculatus (fw). 
At high doses (>0.2 g/g) the swimming capabilities of fishes were reduced, and they 
became paralyzed in as little as 5 min after the injection. Evident dyspnoea, as inferred by 
labored breathing and more rapid gill movement, was also noticed. Unlike what happened 
in mice, all fishes that showed initial signs of envenomation eventually died. For all tested 
species, the values for goodness of fit were not large in fishes (Chi
2
 < 1.4, df=3, p>0.192 in 
all cases), indicating that the data fits the probits model. In addition, the hypothesis of 
parallelism among the fishes and mice data sets was not rejected (Chi
2
= 3.23, df=3, 
p=0.357) thus changes in toxicity per unit change in the doses are similar among the 
species. Ratios for LD50 values were not significantly different between the murine and the 
fish models (Fig.7). 
 In myotoxicity experiments performed in mice, venom doses of 2 g or higher 
injected by the i.m. route resulted in rapid death, precluding blood sampling at an adequate 
time for assessing muscle damage. Therefore, this activity was tested at a maximal dose of 
1 g. At this low dose, no evidence of myonecrosis was recorded, since CK activity levels 
in the plasma of mice that received venom (158 ± 120 U/L) were not significantly different 
from those of mice that received only PBS (217 ± 60 U/L), three hours after injections 
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(p>0.05). Thus, the search for myotoxic activity in the venom was followed by the analysis 
of the isolated, most abundant PLA2. 
 The PLA2 present in peak 9 (Table 1) showed an isotope-averaged mass of 13332 
Da (Fig.5B). This protein was tested for lethality and myotoxicity in mice. No deaths were 
observed at doses of 20 µg, either by i.v. or i.m. routes of injection. Furthermore, a single 
mouse that received 40 µg i.v. also survived, thus indicating that this PLA2 is not 
neurotoxic. However, when the dose of 20 µg was injected i.m., in the gastrocnemius, there 
was a clear increase in the plasma CK activity after three hours. Control mice receiving 
PBS alone showed a CK activity of 307 ± 232 U/L, whereas the activity of plasma of mice 
receiving 20 µg of the PLA2 was 2992 ± 685 U/L (p<0.05), thus indicating that this PLA2 is 
myotoxic. This was confirmed by histological observation of muscle tissue (results not 
shown). At this dose, no macroscopic evidence of myoglobinuria was observed. 
 In vitro, the whole venom of P. platura showed detectable, although weak PLA2 
activity (Fig.4A), which in comparison to the venom of the coral snake M. nigrocinctus 
(Elapidae), included as a control, was markedly lower. On the other hand, P. platura lacked 
cytotoxic effect upon C2C12 myoblasts in culture, also in sharp contrast to the venom of M. 
nigrocinctus, used as a control (Fig.4B). Since a subtype of elapid 3FTxs, the 
cytotoxins/cardiotoxins, typically display a potent in vitro cytolytic effect on many cell 
types [54], this result suggests that the abundant 3FTxs present in P. platura venom do not 
belong to such a subtype. 
 Differentiation of cultured myoblasts into myotubes has been shown to increase 
their susceptibility to certain myotoxins of snake venoms [40,62]. Exposure of 
differentiated myotubes to P. platura venom also led to negative results (data not shown), 
confirming its lack of cytotoxic activity. Interestingly, although its isolated PLA2 induced 
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myotoxicity in vivo, it was not cytolytic when added to myotubes at 25 g/well (165 
g/mL) (data not shown). The behavior of the newly isolated PLA2 myotoxin from P. 
platura coincides with that of notexin, a potent myotoxic PLA2 from the Australian 
terrestrial elapid Notechis scutatus [63,64] which was reported to lack cytotoxicity upon 
myogenic and other cell lines using the same method here tested [40,65]. This finding is in 
sharp contrast with PLA2 myotoxins from viperid venoms, which induce a rapid cytolytic 
effect upon myogenic cells and other cell types [40,65]. Such functional difference suggests 
that myotoxicity of some elapid (group I) and viperid (group II) PLA2s, despite leading to a 
similar pathological outcome, may involve distinct molecular mechanisms, in line with the 
convergent evolutionary processes that independently led to the acquisition of this toxic 
effect in these two groups of PLA2s [66]. 
 Peak 16 was identified as a CRISP (Table 1), which by nESI-MS analysis was 
resolved into three close molecular masses (24459, 24559, and 24661 Da; Fig.5C) that very 
likely correspond to isoforms. CRISPs represent a widely distributed protein family in 
viperid snake venoms [67,68]. Neurotoxic CRISPs have been identified and characterized 
from the Australian elapids Pseudechis australis and P. porphyriacus. These molecules 
target cyclic nucleotide-gated ion channels and inhibit smooth muscle contraction [69,70]. 
However, injecting fraction 16 into mice by the i.v. route, at a dose of 20 g (1.05 g/g), 
did not cause death or any evident behavioral alterations, suggesting that this relatively 
prominent CRISP component of the venom (~9%) does not play a role in its lethal activity, 
at least in mice. It would be of interest to assay the possible effects of this CRISP fraction 
in fish, being the natural prey of P. platura. We were only able to inject a single Dormitator 
maculatus fish of 4.3 g by i.p. route, using 0.29 g/g body weight of the CRISP component, 
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resulting in no evident alterations or lethality. On the other hand, the major 3FTx, 
pelamitoxin (Fig.5A), was highly lethal to mice, with an LD50 of 3.9 g/mouse by the i.p. 
route (95% confidence limits 1.7-8.2 g; 0.23 g/g body weight), in agreement with earlier 
studies of Liu et al. [55] on the characterization of pelamitoxin isolated from specimens 
collected in northern Taiwan. It is worth to note that an LD50 of 3.9 μg pelamitoxin/mouse 
would correspond to an LD50 of 15 μg crude venom/mouse, which is 6.5-fold higher than 
that determined above. This figure suggests that, at least in the mouse model, other venom 
components may contribute synergistically with pelamitoxin to venom lethality. 
 Altogether, the present data indicate that the potent lethal effect of the whole venom 
is mainly mediated by its abundant 3FTxs with -neurotoxic activity, most notably the 
pelamitoxin component (~26%), which probably plays a key role in subduing the elusive 
fish that constitute this snake’s diet. Although functional studies were conducted in mice, 
on the basis of its myotoxic activity and lack of neurotoxicity, we hypothesize that the 
major PLA2 studied here (~20%) might contribute to the muscle digestion of fish prey, but 
would not appear to be involved in lethality. The role of the CRISP proteins in this venom, 
however, remains unknown. 
 Although very rarely described in the literature [17,71-73], potential human 
envenomations by P. platura can raise medical concern due to the unavailability of a 
specific antivenom in many regions of its distribution, as a consequence of the inherent 
difficulties to obtain sufficient venom for the immunization of large animals. Bolaños et al. 
[61] reported an average venom yield as low as 0.38 mg per individual, from specimens 
collected in Guanacaste, Costa Rica. In this regard, the cross-reactivity toward P. platura 
venom of the sea snake antivenom manufactured by the CSL in Australia, using the venom 
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of Enhydrina schistosa as immunogen, was evaluated. In agreement with studies reviewed 
by Mackessy and Tu [17] and Pickwell [74], a clear effectiveness of this antidote in the 
neutralization of the lethal effect of P. platura venom from Costa Rica was confirmed. 
Control mice receiving four LD50 of venom by either the i.v. or the i.p. routes died within 5 
min. In contrast, when venom was incubated with this antivenom (at a ratio of 0.2 mg 
venom/mL antivenom) and then injected by either of these two routes, all the mice survived 
and showed no signs of neurotoxicity. On the other hand, as expected, the possible cross-
neutralization of P. platura venom by the equine antivenom against Micrurus nigrocinctus 
manufactured at Instituto Clodomiro Picado (Costa Rica) was ruled out, since none of the 
mice receiving venom/antivenom mixtures (under the same experimental conditions as for 
the CSL sea snake antivenom) survived (data not shown). Although a full titration of the 
neutralizing potency of the CSL antivenom was not performed owing to the scarcity of P. 
platura venom, results obtained at the fixed level of 0.2 mg/mL clearly imply that 
significant antigenic similarities exist between proteins of E. schistosa and those of P. 
platura venom involved in its lethal effect. The ability of the CSL antivenom in 
neutralizing the toxicity of the venoms of true sea snakes as well as that of the 
taxonomically divergent yellow-lipped sea krait, Laticauda colubrina [75], is consistent 
with the parallel but independent streamlining of both marine lineages, and the low level of 
phylogenetic variation of their 3FTxs [53,76]. 
 Cross-recognition of P. platura venom by the CSL antivenom was further 
characterized by EIA and GID analyses. The antivenom generated a clear precipitin line 
against whole venom by GID, together with an additional, although barely visible diffuse 
precipitate (Fig.6A), and a strong EIA signal in its titration against solid-phase adsorbed 
whole venom (Fig.6B). In addition, GID tests using the three major components of P. 
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platura venom resulted in the formation of three independent precipitation systems against 
the 3FTx, PLA2, and CRISP, respectively, by their corresponding antibodies in CSL 
antivenom (Fig.6C). By solid-phase EIA, a higher signal in the recognition of PLA2, 
followed by the 3FTx, and a weak recognition of CRISP were obtained (Fig.6D). Thus, the 
cross-recognition of P. platura venom by the CSL antivenom involves at least these three 
types of components, PLA2 being more immunogenic than the other two according to EIA 
signals. Finally, in agreement with results of immunochemical tests, the CSL antivenom 
was able to neutralize the lethal effect of the isolated 3FTx, pelamitoxin, at a ratio of 0.2 
mg toxin/mL antivenom: all mice receiving a lethal i.v. injection of the toxin previously 
incubated with the antivenom survived. 
 
 
4. CONCLUDING REMARKS 
 Only 100 species in the snake lineages Acrochordidae, Laticaudinae, 
Homolopsidae, and Hydrophiini have independently colonized marine habitats [76]. The 
Hydrophiini, with 60 species in 19 genera, are the most diverse and widely distributed of all 
the lineages of marine snakes [20,77]. Unsurprisingly, sea snakes possess a number of 
morphological and biochemical adaptations to aquatic life [78]. Noteworthy, the specialized 
venoms of sea snakes tend to be biochemically simple despite being among the most toxic 
venoms known [79]. Lacking the high visual acuity or scent cues used by terrestrial snakes 
to prevent the escape of prey, which in the case of sea snakes consists largely of fish or fish 
eggs, and occassionally squid and cuttlefish, sea snakes have evolved venoms largely 
dependent on rapidly acting, highly toxic neurotoxins. However, sea snakes are not 
particularly aggressive, and human snakebite accidents are rare, occurring mainly among 
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marine fishermen while snakes are being removed from nets. It has been suggested that P. 
platura, with its small mouth and low venom yield, poses little threat to humans. Indeed, 
asymptomatic bites by P. platura have been reported and human deaths caused by this 
species remain unproven [71]. 
 The venoms of P. platura from two localities of Costa Rica that differ strikingly in 
color phenotype do not vary in their protein profiles, as assessed by RP-HPLC. Proteomic 
analyses revealed that the venom of this widely distributed sea snake presents a relatively 
simple composition, including three major types of components that belong to the 3FTx, 
PLA2, and CRISP protein families, respectively. This finding seems to be in concordance 
with the suggestion of Fry and colleagues of a strong functional association between the 
relatively simple venoms of sea snakes and their teleost-based diet of a single vertebrate 
class (fish) [80,81]. In contrast to some terrestrial elapid venoms that possess a complex 
protein pattern with a high number of isoforms, for example that of Micrurus nigrocinctus 
[82], the venom of P. platura might have evolved without a strong pressure for isoform 
diversification through gene duplication and divergence, or alternatively, might have 
undergone a secondary genetic simplification as part of its adaptation to the marine 
environment and a relatively specific type of prey, essentially consisting of small fish [24]. 
Future genomic analyses would be needed to discern between these possibilities. 
Regardless of the evolutionary history, and in line with observations on other marine 
snakes [17,50,81], P. platura presents a limited diversity in its toxic arsenal. An abundant 
3FTx, pelamitoxin, is likely to play the main role in the paralyzing and lethal actions of this 
venom against its natural preys, while at least another major component, a PLA2, is capable 
of damaging skeletal muscle, without causing neurotoxic effects, presumably contributing 
to the initiation of prey digestion. However, due to the scarcity of purified proteins the toxic 
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activity of 3FTxs and PLA2s was only tested in mice, essentially because these experiments 
allowed comparison with reported studies using well-characterized homologous toxins. 
Thus, although the results indicated that the major PLA2 eluted in peak 9 (which accounts 
for ~20% of the total venom proteins) was not lethal to mice, the possibility that this 
protein exhibits taxon-specific activity, as reported for other toxins [83-87], requires future 
detailed investigation. Finally, of relevance from a clinical standpoint, the sea snake 
antivenom manufactured by CSL in Australia using the venom of E. schistosa displays 
sufficient immunological cross-reactivity to provide protection from the lethal effects of P. 
platura venom in preclinical mouse assays, therefore being of potential usefulness in the 
event of envenomations by this species. 
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LEGENDS FOR FIGURES 
 
Figure 1: Two color morphs of Pelamis platura (A, C) from different geographical origins 
in Costa Rica (B), Golfo de Papagayo and Golfo Dulce, respectively, do not express 
differences in their venom protein profiles (see Fig.2). Relative abundances of venom 
protein families are shown as percentages of the total protein content in (C). 3FTx: three-
finger toxins, PLA2: phospholipases A2; CRISP: cyteine-rich secretory proteins; 5'NU: 5'-
nucleotidases; SVMP: metalloproteinases; TRF: transferrins; ALB: albumins; HBG: 
hemoglobins; UNK: unknown/unidentified. 
 
Figure 2: Comparison of the protein elution patterns of the venoms of Pelamis platura 
collected in Golfo de Papagayo and Golfo Dulce, respectively, by reverse-phase HPLC 
fractionation on a C18 column, as described in Methods. 
 
Figure 3: Elution profile of Pelamis platura (Golfo Dulce) venom proteins by reverse-
phase HPLC. Venom (2.1 mg) was fractionated on a C18 column (4.6 x 250 mm) eluted 
with a gradient of acetonitrile containing 0.1% trifluoroacetic acid, as described in 
Methods. The gradient line is omitted for clarity. Venom fractions were analyzed by SDS-
PAGE (top insert), under reducing conditions, in 12% gels, and stained with Coommassie 
blue R-250. Molecular weight markers (M) are indicated in kDa, at the right. The tryptic 
digests of the proteins were characterized by nESI-MS/MS or MALDI-TOF-TOF, as 
described in Methods. The three most abundant venom peaks (indicated by stars), were 
further characterized. 
 
Figure 4: (A) Comparison of the phospholipase A2 activity of Pelamis platura and 
Micrurus nigrocinctus venoms, upon the monodispersed synthetic substrate 4-nitro-3-
octanoyl-benzoic acid (NOBA), as described in Methods. Each point represents mean ± SD 
of triplicate assays. (B) Comparison of the cytolytic activity of P. platura and M. 
nigrocinctus venoms on the myogenic nurine cell line C2C12 in vitro, estimated as the 
release of lactate dehydrogenase 3 hr after exposure of myoblasts to the venoms, as 
described in Methods. Each bars represents mean ± SD of triplicate assays. 
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Figure 5:  Isotope-averaged molecular mass of the three major components (Fig.3) of the 
venom of Pelamis platura (A: peak 1-2, 3FTx; B: peak 9, PLA2; C: peak 16, CRISP) as 
determined by direct infusion nESI-MS on a QTrap3200 instrument (ABSciex) operated in 
positive, enhanced multi-charge mode. Graphs show the corresponding deconvolutions of 
m/z peaks of the multicharged ion series of the intact proteins, using the Analyst v.1.5 
software (ABSciex). 
 
Figure 6: Immunochemical cross-reactivity of the CSL sea snake antivenom (V) toward 
the whole venom of Pelamis platura (A, B) or three isolated components (C, D), evaluated 
by gel immunodiffusion (A,C) or enzyme-immunoassay (B,D). In (C), the major precipitin 
line formed between the antivenom and the venom fuses with the 3FTx line, revealing its 
identity. Precipitin lines formed between antivenom and PLA2 or CRISP components, 
respectively, show a non-identity pattern. In (B) and (D), points or bars represent mean ± 
SD of duplicates, and all differences between antivenom and negative control values are 
significant (p<0.05). 
 
Figure 7: Effect of Pelamis platura venom in Lutjanus guttatus. (A) The crude venom was 
injected by intraperitoneal route at a dose of 0.25 g/g body weight. Death of the individual 
occurred approximately five hours after the injection. Notice the exposed gill filaments and 
arch (arrow) and the wide opening of the mouth, in comparison to the normal control 
individual in (B). 
 
Figure 8: Comparison of the median lethal doses (LD50) of Pelamis platura venom in the 
mouse and three species of fishes. Venom was injected by the intraperitoneal route and 
deaths were scored after 48 h. LD50 values (with 95% confidence intervals indicated by the 
error bars) were calculated by Probits. No significant differences in LD50 are found among 
the four species. 
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Table 1: Assignment of the RP-HPLC isolated fractions of Pelamis platura venom to protein families by nESI-MS-MS or MALDI-
TOF-TOF of selected peptide ions from in-gel trypsin-digested protein bands. 
 
  
Peak % Mass 
[kDa] 
Peptide ion MS/MS-derived or N-terminal (Nt) sequence Sco Protein family;   ~ related protein * 
   m/z z    
1 
 
 
 
 
26.2 6680.4 748.8 
725.3 
465.2 
453.2 
918.3 
2 
2 
2 
2 
2 
MTCCNQQSSQPK 
TTTNCAESSCYK 
KTWSDHR 
GCGCPQVK 
SGIKLECCHTNECNN 
165
a
 short-chain -neurotoxin (pelamitoxin a); P62388 
  
2 - 6704.1 748.8 
775.3 
652.3 
453.2 
918.3 
2 
2 
2 
2 
2 
MTCCNQQSSQPK 
TTTNCAESSCYKK 
IERGCGCPQVK 
GCGCPQVK 
SGIKLECCHTNECNN 
118
a
 short-chain -neurotoxin (pelamitoxin a); P62388 
  
3 0.7 [7] 453.2 
465.2 
2 
2 
GCGCPQVK 
KTWSDHR 
dn short-chain -neurotoxin (pelamitoxin a); P62388 
4a 1.0 [17] 777.4 
453.2 
465.2 
2 
2 
2 
MTCCNQQSSQPK 
GCGCPQVK 
KTWSDHR 
dn short-chain -neurotoxin (pelamitoxin a); P62388 
4b 6.8 [7] 734.8 
775.3 
2 
2 
MTCCNQQSSQPK 
TTTNCAESSCYKK 
102
a
 short-chain -neurotoxin (pelamitoxin a); P62388  
5a 0.4 [14] 620.3 
892.9 
902.4 
2 
2 
2 
MVCDCDVAAAK 
NAYNNANYNIDTNKR 
M
ox
VCDCDVAAAKCFAR 
115
a
 phospholipase A2; ~ Q8UW08 Hydrophis hardwickii 
5b 0.6 [8] 453.2 
 
481.8 
2 
 
2 
GCGCPQVK 
 
(185.1)ELGCTAK 
dn 
 
dn 
short-chain -neurotoxin (pelamitoxin a); P62388 
 
long-chain -neurotoxin; ~ Q8UW29  
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5c 2.1 [7] 481.8 2 (185.1)ELGCTAK dn long-chain -neurotoxin; ~ Q8UW29 
6a 1.5 [16] 601.8 
675.8 
2 
2 
GGSGTPVDELDR 
IHDDCYGEAEK 
40
a
 phospholipase A2; ~ Q9PUI0 
 
6b 1.6 [14] 892.9 
1393.1 
2 
2 
NAYNNANYNIDTNKR 
SSLDYADYGCYCGAGGSGTPVDELDR 
86
a
 phospholipase A2; ~ Q8UW08 
6c 7.0 7725.7 481.8 
514.7 
1070.1 
2 
2 
2 
(185.1)ELGCTAK 
CDGFCSIR 
(312.3)YQPETCPPGQSLCYK 
dn long-chain -neurotoxin; ~ Q8UW29 
7a 0.6 [14] 620.3 
595.6 
1393.1 
 
668.8 
2 
3 
2 
 
2 
MVCDCDVAAAK 
NAYNNANYNIDTNKR 
SSLDYADYGCYCGAGGSGTPVDELDR 
 
IHDDCYGEAEK 
379
a
 
 
 
 
207
a
 
phospholipase A2; ~ Q8UW08 
 
 
 
phospholipase A2; ~ Q8UW30 
7b 0.3 [8] 453.2 
 
481.8 
514.7 
2 
 
2 
2 
GCGCPQVK 
 
(185.1)ELGCTAK 
CDGFCSIR 
 short-chain -neurotoxin (pelamitoxin a); P62388 
 
long-chain -neurotoxin; ~ Q8UW29  
7c 1.3 [7] 1070.1 
514.7 
481.8 
2 
2 
2 
(312.3)YQPETCPPGQSLCYK 
CDGFCSIR 
(185.1)ELGCTAK 
dn long-chain -neurotoxin; ~ Q8UW29 
8a 1.0 [14] 620.3 
595.6 
1393.1 
 
690.6 
 
601.8 
2 
2 
2 
 
4 
 
2 
MVCDCDVAAAK 
NAYNNANYNIDTNKR 
SSLDYADYGCYCGAGGSGTPVDELDR 
 
IHDDCYGEAEKQGCYPK 
 
GGSGTPVDELDR 
223
a
 phospholipase A2; ~ Q8UW08 
 
 
 
phospholipase A2; ~ Q8UW30 
 
phospholipase A2; ~ Q9PUI0 
8b 1.4 [7] 1070.1 
481.8 
507.7 
769.4 
2 
2 
2 
2 
(312.3)YQPETCPPGQSLCYK 
(185.1)ELGCTAK 
CDGFCSIR 
(216.4)TDNCNTVANWK 
dn long-chain -neurotoxin; ~ Q8UW29 
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453.2 
 
2 
 
GCGCPQVK 
 
short-chain -neurotoxin (pelamitoxin a); P62388 
9a 20.2 [14] 619.2 
668.8 
690.6 
1393.1 
1078.1 
 
975.4 
 
595.6 
 
601.8 
2 
2 
3 
2 
3 
 
2 
 
3 
 
2 
KVCDCDVAAAK 
IHDDCYGEAEK 
IHDDCYGEAEKQGCYPK 
SSLDYADYGCYCGAGGSGTPVDELDR 
SSLDYADYGCYCGAGGSGTPVDELDRCCK 
 
NLVQFSYVITCANHNR 
 
NAYNNANYNIDTNKR 
 
GGSGTPVDELDR 
570
a
 phospholipase A2; ~ Q8UW30 
 
 
 
 
 
phospholipase A2; ~ P00610 
 
phospholipase A2; ~ Q8UW08 
 
phospholipase A2; ~ Q9PUI0 
9b 2.1 [7] 481.8 
514.7 
1070.1 
2 
2 
2 
(185.1)ELGCTAK 
CDGFCSIR 
(312.3)YQPETCPPGQSLCYK 
dn long-chain -neurotoxin; ~ Q8UW29 
10 3.7 [14] 620.3 
892.9 
1393.1 
 
668.8 
 
601.8 
2 
2 
2 
 
2 
 
2 
MVCDCDVAAAK 
NAYNNANYNIDTNKR 
SSLDYADYGCYCGAGGSGTPVDELDR 
 
IHDDCYGEAEK 
 
GGSGTPVDELDR 
270
a
 phospholipase A2; ~ Q8UW08 
 
 
 
phospholipase A2; ~ Q8UW30 
 
phospholipase A2; ~ Q9PUI0 
11a 0.4 [14] 620.3 
892.9 
1393.1 
 
668.8 
2 
2 
2 
 
2 
MVCDCDVAAAK 
NAYNNANYNIDTNKR 
SSLDYADYGCYCGAGGSGTPVDELDR 
 
IHDDCYGEAEK 
149
a
 phospholipase A2; ~ Q8UW08 
 
 
 
phospholipase A2; ~ Q8UW30 
11b 0.2 [8] 453.2 
 
481.8 
2 
 
2 
GCGCPQVK 
 
(185.1)ELGCTAK 
dn short-chain -neurotoxin (pelamitoxin a); P62388 
 
long-chain -neurotoxin; ~ Q8UW29  
11c 0.2 [7] 453.2 2 GCGCPQVK dn short-chain -neurotoxin (pelamitoxin a); P62388 
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481.8 
 
2 
 
(185.1)ELGCTAK 
 
long-chain -neurotoxin; ~ Q8UW29  
12 
 
 
 
 
 
 
3.5 [14] 620.3 
595.6 
1393.1 
 
668.8 
 
601.8 
2 
3 
2 
 
2 
 
2 
MVCDCDVAAAK 
NAYNNANYNIDTNKR 
SSLDYADYGCYCGAGGSGTPVDELDR 
 
IHDDCYGEAEK 
 
GGSGTPVDELDR 
212
a
 phospholipase A2; ~ Q8UW08 
 
 
 
phospholipase A2; ~ Q8UW30 
 
phospholipase A2; ~ Q9PUI0 
13 1.6 [38] 
 
579.3 
 
454.7 
 
700.4 
2 
 
2 
 
2 
QGEALNQLER 
 
TLCAQCR 
 
(244.1)LQLNSPFLPK 
dn unknown 
 
5'-nucleotidase;  ~ ETE67245 
 
metalloproteinase; ~ AAR19274 
14 
 
0.5 [14] 634.7 
 
428.3 
2 
 
2 
(YG)WCNNNQGR 
 
GPPNSDGSR 
dn unknown 
15 0.6 - - - no protein band - unknown 
16a 0.9 [58] 433.7 
529.3 
597.8 
671.8 
888.9 
2 
2 
2 
2 
2 
SSIATPYK 
SHLLGCASAK 
EIVDKHNALR 
CTFAHSPEHTR 
YLYVCQYCPAGNIR 
149
a
 cystein-rich secretory protein; ~ Q8UW1 
16b 8.2 24449 
24550 
24649 
433.7 
482.7 
529.3 
597.8 
671.8 
888.9 
1342.5 
2 
2 
2 
2 
2 
2 
3 
SSIATPYK 
CQTEWIK 
SHLLGCASAK 
EIVDKHNALR 
CTFAHSPEHTR 
YLYVCQYCPAGNIR 
SGPSCGDCPSACVNGLCTNPCEYE... 
...DAYTNCNDLVK 
190
a
 cystein-rich secretory protein; ~ Q8UW11 
17 1.8 [92] 469.3 2 VASHAVVVR dn transferrin;  ~ CAK18224 
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769.4 
574.8 
829.9 
2 
2 
2 
ESCAPGASLE(536.3) 
DFPELICVR 
NLLQWSGTESG(486.3) 
 
18a 1.1 [68] 452.2 
578.4 
462.8 
515.3 
2 
2 
2 
2 
FIMTHEK 
AXVVVLLEATK 
LLPQAPASK 
LVEQLQSGR 
dn albumin;  ~ S59517 
18b 0.1 [62] 414.2 2 ETVLLPR 36
a
 metalloproteinase; ~ D6PXE8 
18c 0.2 [28] - - - - unknown 
18d 0.1 [24] 444.7 2 LGEEEVGK     dn unknown 
18e 0.3 [16] 493.2 
532.8 
2 
2 
VHWSAEEK 
VLTSFGEALK 
47 hemoglobin ; ~ P22743 
19 0.8 [15] 1331.7 
2128.2 
1078.7 
1500.8 
1837.9 
1687.9 
985.6 
1 
1 
1 
1 
1 
1 
1 
CFQVSLATHLR 
VIDALTEAVNNLDDVAGALSK 
LFIVFPQSK 
TYFSHYNLSPGSK 
TYFPHFDLSPGSNDLK 
GTLSQLSDLHAYNLR 
LFAAHPTTK 
251 hemoglobin ;  ~ Q7ZT83 
20 1.0 [15] 1500.8 
1837.9 
1054.6 
1687.9 
1288.8 
1 
1 
1 
1 
1 
TYFSHYNLSPGSK 
TYFPHFDLSPGSNDLK 
VFTAFGDAVK 
GTLSQLSDLHAYNLR 
LLIVYPWTQR 
117 hemoglobin , ; ~ P16418 
        
 
* Cysteine residues are carbamidomethylated, unless indicated by underlining, corresponding to propionamide. X: Leu/Ile; B: Lys/Gln; 
ox
: 
oxidized; Sco: probability score values calculated by 
a
Mascot (www.matrixscience.com); dn: manual de novo interpretation of spectra. 
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Graphical abstract 
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Highlights 
 The yellow-bellied sea snake, Pelamis platura, is the most broadly distributed snake species 
 Two distinct color morphs of this sea snake inhabit the Pacific coast of Costa Rica 
 Venoms of both populations are conserved, despite their remarkable color phenotype divergence 
 A proteomic and functional analysis of this highly lethal snake venom is presented 
 Cross-neutralization of this venom by a sea snake antivenom is demonstrated 
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Biological significance 
 Integrative analyses of animal venoms that combine the power of proteomics (venomics) with the characterization of their 
functional and immunological properties are significantly expanding knowledge on these remarkable bioweapons, both from a basic 
and a medical perspective. Costa Rica harbors a unique population of the yellow-bellied sea snake, Pelamis platura, that is restricted to 
a fjord-like gulf (Golfo Dulce). This population differs markedly from oceanic populations found elsewhere along the Pacific coast of 
this country, by presenting a patternless bright yellow coloration, instead of the typical bicolored or tricolored pattern of this species. It 
has been suggested that the dominance of this yellow-morph in Golfo Dulce might reflect gene flow restrictions, caused by the 
oceanographic conditions at this location. The presents study demonstrates that the remarkable phenotypic variation between the two 
color morphs inhabiting Golfo Dulce and Golfo de Papagayo, respectively, is not associated with differences in the expression of 
venoms components, as shown by their conserved RP-HPLC profiles. Proteomic analysis revealed the relatively simple toxin 
composition of P. platura venom, which contains three predominant types of proteins: three-finger toxins (protein abundance: 49.9%), 
phospholipases A2 (32.9%), and cysteine-rich secretory proteins (9.1%), together with few minor components. Further, the 
involvement of these most abundant proteins in the toxic effects of the venom, and their cross-recognition and neutralization by a sea 
snake antivenom produced against the venom of Enhydrina schistosa, were analyzed. 
